Inhibitors of human plasmin derived from the Kunitz domains
US7919462B2 · kind B2 · utility
21Cited by
34References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2007 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Mar 4, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/8114
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention features novel proteins that are homologous to the first Kunitz domain (K1) of lipoprotein-associated coagulation inhibitor (LACI), and are capable of inhibiting plasmin and nucleic acids encoding these proteins. The invention also features the use of such proteins in therapeutic, diagnostic, and clinical methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.